382 related articles for article (PubMed ID: 21355078)
21. B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients.
Baral A; Ye HX; Jiang PC; Yao Y; Mao Y
Oncol Lett; 2014 Sep; 8(3):1195-1201. PubMed ID: 25120686
[TBL] [Abstract][Full Text] [Related]
22. PD-L1 expression and infiltration by CD4
Lee HJ; Shin DH; Lee YJ; Lee SJ; Hwang CS; Kim A; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Park SW
Histopathology; 2020 Apr; 76(5):714-721. PubMed ID: 31841221
[TBL] [Abstract][Full Text] [Related]
23. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
Krambeck AE; Thompson RH; Dong H; Lohse CM; Park ES; Kuntz SM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10391-10396. PubMed ID: 16798883
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.
Azuma T; Sato Y; Ohno T; Azuma M; Kume H
PLoS One; 2020; 15(12):e0243379. PubMed ID: 33306717
[TBL] [Abstract][Full Text] [Related]
25. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
26. Combination immunotherapy with interleukin-2 surface-modified tumor cell vaccine and programmed death receptor-1 blockade against renal cell carcinoma.
Zhang X; Shi X; Li J; Hu Z; Gao J; Wu S; Long Z
Cancer Sci; 2019 Jan; 110(1):31-39. PubMed ID: 30343514
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
Zhang C; Li Y; Wang Y
J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
[TBL] [Abstract][Full Text] [Related]
28. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
Wu K; Kryczek I; Chen L; Zou W; Welling TH
Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma.
Huang L; Zhou Y; Sun Q; Cao L; Zhang X
Cancer Biomark; 2022; 33(1):123-129. PubMed ID: 34459388
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
[TBL] [Abstract][Full Text] [Related]
31. TLR4-induced B7-H1 on keratinocytes negatively regulates CD4
Zhang J; Tan YQ; Wei MH; Ye XJ; Chen GY; Lu R; Du GF; Zhou G
Exp Dermatol; 2017 May; 26(5):409-415. PubMed ID: 27762043
[TBL] [Abstract][Full Text] [Related]
32. Soluble PD-L1 and B7-H4 serum levels during the course of physiological pregnancy.
Mach P; Köninger A; Reisch B; Kimmig R; Gellhaus A
Am J Reprod Immunol; 2022 Mar; 87(3):e13519. PubMed ID: 34974633
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of serum soluble B7-H3 in nonsmall cell lung cancer.
Li Y; Xu L; Li J; Wang Q; Ma J
Anticancer Drugs; 2024 Jun; 35(5):426-432. PubMed ID: 38386015
[TBL] [Abstract][Full Text] [Related]
34. Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
Azuma T; Sato Y; Ohno T; Azuma M; Kume H
PLoS One; 2018; 13(7):e0199719. PubMed ID: 30044793
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of B7-CD28 costimulation in urologic malignancies.
Thompson RH; Kwon ED; Allison JP
Immunotherapy; 2009 Jan; 1(1):129-39. PubMed ID: 20445772
[TBL] [Abstract][Full Text] [Related]
36. Soluble B7-H3 in Ovarian Cancer and Its Predictive Value.
Kovaleva OV; Belova TP; Korotkova EA; Kushlinskii DN; Gratchev AN; Petrikova NA; Kudlay DA; Kushlinskii NE
Bull Exp Biol Med; 2021 Aug; 171(4):472-474. PubMed ID: 34542756
[TBL] [Abstract][Full Text] [Related]
37. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
38. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.
Dong H; Strome SE; Matteson EL; Moder KG; Flies DB; Zhu G; Tamura H; Driscoll CL; Chen L
J Clin Invest; 2003 Feb; 111(3):363-70. PubMed ID: 12569162
[TBL] [Abstract][Full Text] [Related]
39. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
